Clinical Trials Browser

Phase 2 × Vancomycin × 90 days × Clear all

NCT03030248 2026-04-15

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Phase 2 Completed

9 enrolled 9 charts

Clostridium Infections, Hematologic Diseases

NCT04983901 2026-04-06

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Phase 2 Completed

100 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms